These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
BofA raised the firm’s price target on Madrigal Pharmaceuticals (MDGL) to $239 from $154 and keeps an Underperform rating on ...
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback